Androgenetic alopecia treatment market seen reaching $3.37 billion by 2030

By AI, Created 9:49 AM UTC, May 20, 2026, /AGP/ – The global androgenetic alopecia treatment market is projected to grow from $2.62 billion in 2026 to $3.37 billion by 2030, driven by higher hair-loss awareness, more treatment options and wider use of teledermatology and device-based therapies. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - The market is expanding as more people seek treatment for hair loss, creating demand across medications, procedures and digital care. - Growth in minimally invasive options, personalized treatment and remote consultation could reshape how patients access hair-restoration care. - The report points to a larger global market opportunity for dermatology clinics, drug makers and device companies.

What happened: - The Business Research Company released its “Androgenetic Alopecia Treatment Global Market Report 2026 - Market Size, Trends, And Global Forecast 2026-2035.” - The report estimates the market will rise from $2.44 billion in 2025 to $2.62 billion in 2026, a 7.2% CAGR. - The report forecasts the market will reach $3.37 billion by 2030, growing at a 6.5% CAGR. - The release was dated May 8, 2026, from London. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific will be the fastest-growing region over the forecast period. - The company offers a free sample of the report and the full market report.

The details: - The report links historical growth to wider public awareness of hair-loss remedies, rising androgenetic alopecia prevalence, increased use of finasteride and minoxidil, more dermatology clinics and continued acceptance of hair-transplant procedures. - The report says growth through 2030 will be supported by laser and device-based therapies, precision medicine approaches, artificial intelligence in diagnosis, teledermatology expansion and demand for minimally invasive restoration. - The report highlights emerging trends in tailored hair-loss treatments, natural and herbal options, remote consultation models and combination therapies. - Androgenetic alopecia affects both men and women. - Male-pattern baldness usually starts with a receding hairline. - Female-pattern hair loss often appears as diffuse thinning over the crown. - Genetics and androgen hormones, especially dihydrotestosterone, drive hair-follicle miniaturization. - The report says hair loss can also stem from nutritional deficiencies, hormonal imbalances, genetics and stress. - The release cites NHS data from 2024 showing about 8 million women and 6.5 million men in the UK suffer from hair loss. - The release also cites more than 650,000 hair transplants performed annually in the UK. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The forecast suggests the market is moving beyond classic drug treatment toward a mix of drug, device, surgical and digital-care models. - The faster growth expected in Asia-Pacific suggests demand is broadening beyond mature markets, likely on the back of rising awareness and access. - The mention of AI and teledermatology signals a shift toward earlier diagnosis and more convenient care pathways.

What’s next: - The market is expected to keep growing through 2030 as treatment choices widen and more patients seek care. - Further adoption of minimally invasive and combination therapies may increase competition among providers and product developers. - More growth could follow if teledermatology and AI-assisted diagnosis continue to expand.